Dr. Majed Chane, MD

Dr. Chane practices at California Heart Specialists Inc in Huntington Beach, California.

Dr. Chane's NPI, 1184662629, was assigned on June 4, 2006. Dr. Chane graduated from Damascus University Faculty of Medicine in 1994. Dr. Chane's California license number on file is AO64376.

Dr. Chane's primary practice is California Heart Specialists Inc, at 18800 Main St, Huntington Beach, CA 92648 in Orange County. The practice phone is (714) 842-8100.

Dr. Chane's primary practice is California Heart Specialists Inc in Huntington Beach, California. Dr. Chane is also affiliated with Huntington Beach Hospital. The medical group on file is CA Heart and Vein Specialists. Dmand AI also links Dr. Chane to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chane practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Chane's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Chane is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Chane's licenses on file in 2 states: California and Arizona.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension and coronary artery disease among the conditions Dr. Chane treats.

CMS data shows 6,319 Medicare services from Dr. Chane across 33 procedure codes in 2024, for 663 Medicare patients. Medicare paid $943,961 for them.

CMS counts 663 Medicare patients who saw Dr. Chane in 2024. The largest group is 65 to 74, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chane's median patient age at 65, with 52% women.

In 2024, Dr. Chane wrote 4,343 Medicare Part D claims for 421 patients. 82% of them were for generic drugs. CMS names the drug for 4,108 of them, across 54 drugs with 11 or more claims each, at $486,352 in total drug cost. In 2023, CMS named 3,775 claims across 51 drugs.

Dr. Chane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 315 procedures of varicose vein removal by Dr. Chane, more than 94% of the clinicians it reports for that procedure.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Chane.

Dmand AI links Dr. Chane to 3 clinical trials. Conditions studied include Anemia, Iron-Deficiency, Diabetes Mellitus, Type 2 and Obesity. Open Payments lists research payments to Dr. Chane that name 1 trial.

CMS Open Payments shows 474 general payments to Dr. Chane from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,346. It also lists 1 research payment totaling $1,195 in 2021, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Chane, most recently ACP Fellow in 2004.

Dr. Chane graduated from Damascus University Faculty of Medicine in 1994. Dr. Chane is a member of ACC and ACP.

Dr. Chane is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.